Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation

被引:0
|
作者
Mcgrath, Joseph [1 ]
Rhatigan, Dillin J. [1 ]
Donahue, Danielle [1 ]
Fannin, Mackenzie [1 ]
Lawson, Nuria [2 ]
机构
[1] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Davie, FL USA
[2] Palmetto Gen Hosp, Gen Surg, Miami, FL 33016 USA
关键词
male breast cancer; bard1; mutation; general surgery; infiltrating ductal carcinoma (idc); modified radical mastectomy (mrm); alnd; - axillary lymph node dissection; rare gene mutation; mutyh mutation; SURVIVAL; CANCER;
D O I
10.7759/cureus.66216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Male breast cancer is an uncommon diagnosis with limited research on management and prognosis due to its rarity. We discuss a case of a 55-year-old male with a non-contributory past medical history who presented with an enlarging palpable mass of his right breast tissue at the 10:00 position. The ultrasound of the right breast showed a 2.8 cm heterogenous mass with irregular borders highly suspicious for malignancy. The follow-up sonogram-guided core biopsy was performed, and the pathology of the mass confirmed highgrade infiltrating ductal carcinoma. A modified radical mastectomy of the right breast with extensive axillary lymph node excision was performed. Genetic testing of the excised tumor revealed a MUTYH gene mutation and a BARD1 (BRCA1-associated RING domain 1) gene mutation of unknown significance. Histopathological analysis confirmed a Grade 2, ER/PR-positive, KI 67-positive, and HER2-negative tumor.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Gynecomastia With Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Associated With Invasive Breast Carcinoma in a Male Patient on Antiretroviral Therapy: A Case Report
    Coyne, John D.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (02) : 139 - 141
  • [32] Cyclins D1 & E in infiltrating ductal carcinoma of the breast
    Sweeney, S
    Haber, F
    Reale, F
    Savas, L
    Khan, A
    LABORATORY INVESTIGATION, 1997, 76 (01) : 134 - 134
  • [33] Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1β Scaffolds Aurora B and BRCA2
    Ryser, Stephan
    Dizin, Eva
    Jefford, Charles Edward
    Delaval, Benedicte
    Gagos, Sarantis
    Christodoulidou, Agni
    Krause, Karl-Heinz
    Birnbaum, Daniel
    Irminger-Finger, Irmgard
    CANCER RESEARCH, 2009, 69 (03) : 1125 - 1134
  • [34] Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family.
    Debrakeleer, S.
    De Greve, J.
    Kracj, M.
    Sermijn, E.
    Fontaine, C.
    Goelen, G.
    Bonduelle, M.
    Novakovic, S.
    Teugels, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S184 - S184
  • [35] BRCA1 and BARD1 expression and localization in breast cell lines
    Herrera, Cristobal
    Perez, Elisa
    Blanco, Elias
    Gajardo, Patricia
    Carvallo, Pilar
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Prognosis of infiltrating lobular versus infiltrating ductal carcinoma of the breast.
    Buchanan, C
    Alleyne, R
    Holmes, DR
    Silverstein, MJ
    Nakamura, SK
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S43 - S43
  • [37] Exploring prevalence of BARD1 pathogenic variant in breast cancer patients
    Valintelis, Albertas
    Drejeriene, Ieva
    Norvydas, Matas
    Gruode, Jurate
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 905 - 905
  • [38] Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe, Upali W.
    Bilous, A. Michael
    Boyages, John
    BREAST JOURNAL, 2007, 13 (05): : 479 - 485
  • [39] Comparative survival analysis of infiltrating ductal carcinoma versus infiltrating lobular carcinoma of the breast
    Burgos, C. Huertas
    Parra, L. Beltran
    Ferrandez, M. C. Sanz
    Valiente, L. Alvaro
    Chapinal, B. Garcia
    Vozmediano, M. Arroyo
    Alvarez, M. Gallego
    Guerrero, M. Blanco
    Sanchez, S. Aragon
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 36 - 36
  • [40] Mutational analysis of BARD1 in familial breast cancer patients in Japan
    Ishitobi, M
    Miyoshi, Y
    Hasegawa, S
    Egawa, C
    Tamaki, Y
    Monden, M
    Noguchi, S
    CANCER LETTERS, 2003, 200 (01) : 1 - 7